We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+2.63%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.75B
AUM Growth
+$9.65M
Cap. Flow
+$34.6M
Cap. Flow %
1.26%
Top 10 Hldgs %
19.17%
Holding
309
New
22
Increased
110
Reduced
75
Closed
74

Top Buys

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$25.8M
2
FATE icon
Fate Therapeutics
FATE
+$13.9M
3
IMGO
Imago BioSciences, Inc. Common stock
IMGO
+$12.3M
4
STER
Sterling Check Corp. Common Stock
STER
+$10.8M
5
SKYT icon
SkyWater Technology
SKYT
+$9.26M

Top Sells

Rank Stock Value
1
AZEK
The AZEK Co
AZEK
+$19.8M
2
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$18.5M
3
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$17.9M
4
EVER icon
EverQuote
EVER
+$13M
5
ECHO
Echo Global Logistics, Inc.
ECHO
+$12.4M

Sector Composition

Rank Sector Weight
1 Technology 21.64%
2 Healthcare 20.11%
3 Consumer Discretionary 16.66%
4 Industrials 15.03%
5 Financials 13.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
S icon
276
SentinelOne
S
$6.22B
– –
-1,000
Closed -$43K
SEER icon
277
Seer Inc
SEER
$108M
– –
-211,122
Closed -$6.92M
SEM
278
DELISTED
Select Medical
SEM
– –
-5,252
Closed -$120K
SHLS icon
279
Shoals Technologies Group
SHLS
$1.58B
– –
-10,430
Closed -$370K
TGT icon
280
Target
TGT
$62.1B
– –
-130
Closed -$31K
THG icon
281
Hanover Insurance
THG
$7.63B
– –
-1,030
Closed -$140K
TIGO icon
282
Millicom
TIGO
$15.8B
– –
-22
Closed -$1K
UIS icon
283
Unisys
UIS
$227M
– –
-6,660
Closed -$169K
UTZ icon
284
Utz Brands
UTZ
$1.25B
– –
-19,775
Closed -$431K
VMEO
285
DELISTED
Vimeo
VMEO
– –
-2,078
Closed -$102K
VSH icon
286
Vishay Intertechnology
VSH
$5.86B
– –
-8,350
Closed -$188K
TECX
287
Tectonic Therapeutic
TECX
$573M
– –
-57,417
Closed -$6.13M
TBCH
288
Turtle Beach Corp
TBCH
$239M
– –
-2,500
Closed -$80K
XYZ
289
Block Inc
XYZ
$45.9B
– –
-1,330
Closed -$324K
ATSG
290
DELISTED
Air Transport Services Group
ATSG
– –
-5,490
Closed -$128K
SUM
291
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
– –
-521,125
Closed -$17.9M
DCPH
292
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-8,865
Closed -$325K
MRTX
293
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-300
Closed -$48K
LTHM
294
DELISTED
Livent Corporation
LTHM
– –
-1,071
Closed -$21K
TRHC
295
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
– –
-3,106
Closed -$155K
EMAN
296
DELISTED
eMagin Corporation
EMAN
– –
-1,000
Closed -$3K
ONEM
297
DELISTED
1Life Healthcare
ONEM
– –
-490
Closed -$16K
TWTR
298
DELISTED
Twitter, Inc.
TWTR
– –
-100
Closed -$7K
CVET
299
DELISTED
Covetrus, Inc. Common Stock
CVET
– –
-386,721
Closed -$10.4M
DRNA
300
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-495,638
Closed -$18.5M
9 10 11
12
13

Similar funds

FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FAM
Foxhaven Asset Management Charlottesville, Virginia $3.19B AUM 12.34% 1-Year Est. Return

Emerald Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, Emerald Advisers held 309 positions worth $2.75B, up 0.35% from $2.74B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Emerald Advisers's Q3 2021 filing shows 22 new, 110 increased, 75 reduced and 74 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 207,006 shares worth $28.8M. The largest sale was The AZEK Co, an estimated $19.8M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Emerald Advisers's largest Q3 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 207,006 shares worth $28.8M.
  • Emerald Advisers added most to SkyWater Technology in Q3 2021, an estimated $9.26M increase.
  • Emerald Advisers's biggest Q3 2021 reduction was EverQuote, cutting an estimated $13M.
  • Emerald Advisers fully exited The AZEK Co in Q3 2021, selling an estimated $19.8M.
  • Emerald Advisers's ten largest holdings make up 19% of its $2.75B portfolio in Q3 2021.
  • Emerald Advisers opened 22 new positions and closed 74 in Q3 2021.
  • Emerald Advisers's portfolio value rose 0.35% quarter-over-quarter to $2.75B.

Based on Emerald Advisers's 13F filing for Q3 2021, filed 28 Oct 2021.